Skip to main content

United States

Dentsply Sirona and AADOCR Name 2026 SCADA Award Winners Across Clinical and Translational Dental Research

Image
Dentsply Sirona and AADOCR Name 2026 SCADA Award Winners Across Clinical and Translational Dental Research

SHERIDAN, WYOMING - May 13, 2026 - Dentsply Sirona and the American Association for Dental, Oral, and Craniofacial Research (AADOCR) have announced the winners of the 2026 Student Competition for Advancing Dental Research and its Application (SCADA) Awards, recognizing pre-doctoral dental students for research excellence across clinical and basic science disciplines. The awards were presented during the 55th Annual Meeting of AADOCR, held in conjunction with the 104th General Session and Exhibition of the IADR and the 50th Annual Meeting of the Canadian Association for Dental Research, at the San Diego Convention Center from March 25 to 28, 2026. This year's competition drew 61 dental students from across the United States and seven international finalists from Canada, France, Thailand, Taiwan, South Korea, and Japan.

TuHURA Biosciences CEO to Present Phase 3 Oncology Pipeline at H.C. Wainwright BioConnect Conference

Image
TuHURA Biosciences to Highlight Phase 3 Immuno-Oncology Pipeline at H.C. Wainwright BioConnect Conference

SHERIDAN, WYOMING - May 13, 2026 - TuHURA Biosciences, Inc. (NASDAQ: HURA), a Phase 3 immuno-oncology company focused on overcoming resistance to cancer immunotherapy, has confirmed that President and Chief Executive Officer James A. Bianco, M.D., will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference in New York City on May 19, 2026, at 2:00 pm ET. The appearance gives institutional investors and sector analysts direct access to leadership at a moment when TuHURA is running an active Phase 3 registration trial and advancing two additional pipeline programs. For stakeholders tracking immuno-oncology development timelines and clinical positioning, the session represents a structured opportunity to assess the company's near-term milestones.

Septodont's Biodentine and BioRoot Flow Clinical Data Reshape Restorative and Endodontic Protocols in 2026

SHERIDAN, WYOMING - April 4, 2026 - Dental clinicians managing deep cavity restorations and endodontic retreatment decisions now have a richer evidence base to draw from, as Septodont USA's February 2026 clinical newsletter consolidates two-year trial outcomes for BioRoot® Flow and four documented case studies applying Biodentine® in the Bio-Bulk Fill technique for indirect restorations.

Biodentine Bio-Bulk Fill: four clinical cases document deep cavity restoration

Septodont's Case Studies Collection 28 presents workflows from four clinicians who used Biodentine®'s dentine-like mechanical and biological properties to restore deep cavities using the Bio-Bulk Fill technique. The cases extend the application of the material to symptomatic cracked teeth - a notoriously difficult clinical scenario where pulp status is uncertain and cavity geometry is irregular.

AdvaMed urges House action after Senate approves SBIR and STTR reauthorization

WASHINGTON, 4 March 2026: AdvaMed said the U.S. Senate has approved legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, and the association called on the House of Representatives to move quickly on passage. The medtech trade group said the vote matters because authorization for the two programs lapsed on 30 September 2025, leaving early-stage medical technology companies without the certainty they need as they pursue product research and development.

What the Senate action changes

SHERIDAN, WYOMING - March 31, 2026 - Early-stage medtech companies could regain a key non-dilutive funding route in 2026 after the Senate passed legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, reducing uncertainty that has persisted since the programs' authorization lapsed on September 30, 2025. AdvaMed said the Senate action restores momentum for grants that support early research and development at startups and small manufacturers, and it urged the House of Representatives to move quickly on passage. The association framed the programs as an important bridge for companies that struggle to finance next-generation device development before products reach patients or later-stage commercial milestones.

Roche reports Phase II obesity data for petrelintide with 10.7% weight reduction at 42 weeks

Image

SHERIDAN, WYOMING - March 13, 2026 - Roche has reported positive Phase II results for petrelintide, an amylin analog being developed for people living with overweight and obesity. According to the company, petrelintide delivered up to 10.7% mean body weight reduction at week 42 compared with 1.7% for placebo, with a p-value of less than 0.001. Roche also said the maximally effective dose showed placebo-like tolerability, with no vomiting cases and no treatment discontinuations due to gastrointestinal adverse events. For the obesity treatment market, the update is relevant because efficacy and tolerability remain central to prescribing, adherence and competitive positioning.

CPGIO Broadens Omnichannel Marketplace Reach to Help Brands Scale Across Major Retail Platforms

Image
CPGIO Broadens Omnichannel Marketplace Reach to Help Brands Scale Across Major Retail Platforms

SHERIDAN, WYOMING - December 30, 2025 - CPGIO says it has expanded its digital retail footprint by launching on multiple major marketplaces, positioning the company to support consumer brands with broader omnichannel distribution across a mix of mass, specialty, and B2B wholesale platforms.

Multi-marketplace expansion and timing

The company reported successful launches across Nordstrom, Chewy, Lowe's, Faire, and Best Buy, with the rollout beginning in November 2025. For consumer brands, the announcement signals a continued push toward diversified third-party marketplace presence as a growth lever, particularly as retailers extend marketplace models beyond core categories. For service providers and operators, the business impact typically centers on onboarding speed, catalog and content compliance, inventory synchronization, and the ability to manage pricing and pack-out strategy consistently across channels.

PSEG Long Island Secures LIPA Operating Contract Extension as New Leadership Takes Charge

Image
PSEG Long Island Secures LIPA Operating Contract Extension as New Leadership Takes Charge

SHERIDAN, WYOMING - December 30, 2025 - Public Service Enterprise Group (PSEG) says New York State's comptroller has granted final approval for an extension of PSEG Long Island's operations services agreement with the Long Island Power Authority (LIPA), locking in continued grid-operations responsibilities through the end of 2030.

Contract extension now fully cleared

PSEG said the LIPA Board of Trustees awarded PSEG Long Island a five-year extension of the existing contract on September 25, followed by approval from the New York State attorney general in October and final approval from the comptroller this week. The extension begins January 1, 2026, and runs through December 31, 2030. PSEG Long Island has operated the electric grid on behalf of LIPA since 2014, covering Long Island and the Rockaways.

Yokohama AVID GT Selected as OEM Tire for New Nissan LEAF, Advancing EV-Focused Tire Strategy

Image
Yokohama AVID GT Selected as OEM Tire for New Nissan LEAF, Advancing EV-Focused Tire Strategy

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber has expanded its presence in the electric vehicle supply chain as Nissan chooses the AVID GT as original equipment for the new Nissan LEAF in the United States, underlining the growing role of EV-optimized tire technology in improving range, comfort and safety for mainstream electric cars.

EV-Optimized Tires for a Core Mass-Market Electric Vehicle

Yokohama Rubber has begun supplying its AVID GT in size 215/55R18 95H as factory equipment for the latest Nissan LEAF EV launched in the U.S. market in 2025. Positioned as a key electric model for drivers transitioning from internal combustion engines to battery-electric vehicles, the new LEAF benefits from a tire package specifically engineered to support higher curb weights, instant torque and demanding efficiency targets.